SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors

BACKGROUND: Convalescent plasma therapy is a leading treatment for conferring temporary immunity to COVID-19–susceptible individuals or for use as post-exposure prophylaxis. However, not all recovered patients develop adequate antibody titers for donation and the relationship between avidity and neu...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Infect Dis
Egile Nagusiak: Benner, Sarah E, Patel, Eshan U, Laeyendecker, Oliver, Pekosz, Andrew, Littlefield, Kirsten, Eby, Yolanda, Fernandez, Reinaldo E, Miller, Jernelle, Kirby, Charles S, Keruly, Morgan, Klock, Ethan, Baker, Owen R, Schmidt, Haley A, Shrestha, Ruchee, Burgess, Imani, Bonny, Tania S, Clarke, William, Caturegli, Patrizio, Sullivan, David, Shoham, Shmuel, Quinn, Thomas C, Bloch, Evan M, Casadevall, Arturo, Tobian, Aaron A R, Redd, Andrew D
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2020
Gaiak:
Major Articles and Brief Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7499592/
https://ncbi.nlm.nih.gov/pubmed/32910175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiaa581
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak